4-hydroxycyclophosphamide has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Dalesio, O; de Jonge, ME; Huitema, AD; Mathôt, RA; Rodenhuis, S | 1 |
| Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM | 1 |
| McCune, JS; McDonald, GB; Phillips, B; Ren, AG; Salinger, DH; Shen, DD; Slattery, JT; Vicini, P | 1 |
| Beijnen, JH; Huitema, AD; Kerbusch, T; Rodenhuis, S; Tibben, MM | 1 |
| Kaulfersch, W; Slavc, I; Teubl, I; Urban, C | 1 |
1 trial(s) available for 4-hydroxycyclophosphamide and Neoplasms
| Article | Year |
|---|---|
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide | 2005 |
4 other study(ies) available for 4-hydroxycyclophosphamide and Neoplasms
| Article | Year |
|---|---|
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thiotepa; Triethylenephosphoramide | 2002 |
Real-time dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approach.
Topics: Bayes Theorem; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Models, Biological; Neoplasms; Nonlinear Dynamics; Phosphoramide Mustards; Software; Transplantation Conditioning | 2006 |
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Cyclophosphamide; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Microsomes; Neoplasms; Thiotepa; Time Factors | 2000 |
[Use of autologous bone marrow transplantation in pediatric malignant diseases--results and conclusions].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Freezing; Humans; Infant; Leukemia; Male; Neoplasms; Prognosis; Tissue Preservation | 1987 |